Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. Fagron Compounding Services
EIR
•Fagron Compounding Services•March 24, 2022

Fagron Compounding Services – FDA EIR, Mar 24, 2022

Record Details

An FDA inspection of Fagron Compounding Services (also known as Fagron Sterile Services), a registered 503B Outsourcing Facility in Wichita, KS, was conducted from March 1 to March 24, 2022. The inspection focused on the company's production of human sterile drug products under the regulatory framework for outsourcing facilities. Six significant issues were identified, leading to the issuance of an FDA Form 483. Key violations included deficiencies in the cleaning and disinfection systems for aseptic processing areas, a lack of qualification and proper recording for equipment used in batch records, and the absence of written procedures for in-process controls and examinations. Additionally, the facility failed to ensure drug product testing and release conformed to final specifications prior to distribution, and the quality control unit did not adequately review and approve laboratory control mechanisms. Most notably, the company was observed compounding drug products using bulk drug substances that do not comply with Section 503B of the Act, meaning they were not on the drug shortage list or an FDA-developed list for clinical need. Management was reminded of their responsibility to adhere to drug Current Good Manufacturing Practices (cGMPs) and the potential consequences of non-compliance. Fagron Compounding Services is required to submit a formal response to the FDA within 15 business days addressing these observations.

Company
Fagron Compounding Services
Inspection date
March 24, 2022
Product type
drugs
Office
Kansas City District Office
People
  • Anthony J. Ladner (Pharmacist at U.S. Public Health Service Commissioned Corps)
  • Alan M. Barker (Investigator)
View Company Profile

ID · 3a68514b-fe80-4a86-8020-818b7bb89e57

Violation Codes10
FD&C Act 503B(a)(5)FD&C Act 503B(d)(2)FD&C Act 510FD&C Act 503B(a)(2)(C)FD&C Act 506E21 CFR 216.24FD&C Act 503B(a)(10)(A)21 CFR 310.305FD&C Act 503B21 CFR 211.42(c)(10)(v)

Full citation text and observation details available on the Dashboard.

Other documents for Fagron Compounding Services
  • 483 - 2025-08-08August 8, 2025
  • 483 - 2024-06-28June 28, 2024
  • WARNING_LETTER - 2024-06-28June 28, 2024
  • 483 - 2022-03-24March 24, 2022
  • 483 - 2019-06-21June 21, 2019

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Fagron Compounding Services
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.